Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 10:2021:6660930.
doi: 10.1155/2021/6660930. eCollection 2021.

A Systematic Review and Meta-Analysis of Risk Factors Associated with Severity and Death in COVID-19 Patients

Affiliations
Review

A Systematic Review and Meta-Analysis of Risk Factors Associated with Severity and Death in COVID-19 Patients

Pengqiang Du et al. Can J Infect Dis Med Microbiol. .

Abstract

This meta-analysis aims to screen the risk factors for severe illness and death and provide help for early clinical treatment of the new coronavirus (COVID-19). Based on a comprehensive search of PubMed, Embase, and Web of Science databases, we included studies that explored the cause and risk factors for severe illness and death in COVID-19 patients. We evaluated the strength of this relationship using odds ratios (ORs) with 95% confidence intervals (CIs). A total of 17 articles were included; 16 of the 17 articles were from China, and the risk factors associated with severe illness and death were age, sex, and multiple comorbidities. Advanced age (≥65 years, severe illness, OR = 2.62; death, OR = 6.00), male (severe illness, OR = 1.49; death, OR = 1.54), chronic respiratory diseases (severe illness, OR = 5.67; death, OR = 3.72), diabetes (severe illness, OR = 3.27; death, OR = 2.60), hypertension (severe illness, OR = 3.08; death, OR = 3.53), chronic kidney disease (severe illness, OR = 3.59; death, OR = 5.38), and cardiovascular diseases (severe illness, OR = 3.87; death, OR = 4.91) were all risk factors. For COVID-19 patients, advanced age, male, and patients with chronic disease are at higher risk of developing severe illness or even death.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest associated with the publication of this manuscript.

Figures

Figure 1
Figure 1
Flowchart of the identification of eligible trials.
Figure 2
Figure 2
Meta-analysis results of the association between risk factors and death. (a) Advanced age vs. young age. (b) Male vs. female. (c) Chronic lung diseases. (d) Diabetes. (e) Hypertension. (f) Chronic kidney disease. (g) Cardiovascular disease.
Figure 3
Figure 3
Meta-analysis results of the association between risk factors and severity. (a) Advanced age vs. young age. (b) Male vs. female. (c) Smoking vs. no smoking. (d) Chronic lung diseases. (e) Diabetes. (f) Hypertension. (g) Chronic kidney disease. (h) Cardiovascular disease.
Figure 4
Figure 4
Funnel plots of meta-analysis including (a) sex and severe, (b) diabetes and severe, (c) hypertension and severe, and (d) cardiovascular disease and severe.

References

    1. Guan W. J., Ni Z. Y., Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Wu Z., McGoogan J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323(13):p. 1239. doi: 10.1001/jama.2020.2648. - DOI - PubMed
    1. Moher D., Liberati A., Tetzlaff J., Altman D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:p. b2535. doi: 10.1136/bmj.b2535. - DOI - PMC - PubMed
    1. Hayden J. A., van der Windt D. A., Cartwright J. L., Côté P., Bombardier C. Assessing bias in studies of prognostic factors. Annals of Internal Medicine. 2013;158(4):280–286. doi: 10.7326/0003-4819-158-4-201302190-00009. - DOI - PubMed
    1. Zhang J., Wang X., Jia X., et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clinical Microbiology and Infection. 2020;26(6):767–772. doi: 10.1016/j.cmi.2020.04.012. - DOI - PMC - PubMed

LinkOut - more resources